IDiyas

For the Inventor, By the Inventor

Frankfurt am Main, Germany

Thomas Boehme

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal10 out of 1,451 
 
Sanofi
 patents

Years Active: 2014-2021

where 'Filed Patents' based on already Granted Patents

10 patents (USPTO):
1. 11098102 - Insulin conjugates (2021-08-24),
2. 8901114 - Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof (2014-12-02),
3. 8895547 - Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof (2014-11-25),
4. 8871758 - Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof (2014-10-28),
5. 8846666 - Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof (2014-09-30),
6. 8828995 - Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof (2014-09-09),
7. 8828994 - Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof (2014-09-09),
8. 8809325 - Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof (2014-08-19),
9. 8809324 - Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof (2014-08-19),
10. 8710050 - Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof (2014-04-29),

Title: Thomas Boehme: Innovator in Pharmaceutical Chemistry

Introduction

Thomas Boehme is a prominent inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative insulin conjugates and oxathiazine derivatives. With a total of 10 patents to his name, Boehme's work has the potential to impact the treatment of various medical conditions.

Latest Patents

One of Boehme's latest patents focuses on insulin conjugates. This invention relates to a conjugate comprising a sulfonamide and an active pharmaceutical ingredient, such as an insulin analog with specific mutations. The insulin analog features a mutation at position B16, which is substituted with a hydrophobic amino acid, and/or a mutation at position B25, also substituted with a hydrophobic amino acid. Additionally, the invention includes a sulfonamide of a specific formula and an insulin analog with at least one mutation relative to the parent insulin.

Another significant patent involves oxathiazine derivatives substituted with carbocycles or heterocycles. This invention describes compounds that are suitable for treating hyperglycemia and includes physiologically acceptable salts of these compounds.

Career Highlights

Thomas Boehme is currently associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on innovative solutions in the pharmaceutical industry. His expertise in pharmaceutical chemistry has led to the development of groundbreaking inventions that address critical health issues.

Collaborations

Boehme has collaborated with notable colleagues, including Stefan Guessregen and Christian Engel. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared goals in pharmaceutical research.

Conclusion

Thomas Boehme is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of medical conditions. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…